37 related articles for article (PubMed ID: 38572662)
1. Leukostasis: Management to Prevent Crisis in Acute Leukemia
.
Blackburn LM; Brown S; Munyon A; Orovets M
Clin J Oncol Nurs; 2017 Dec; 21(6):E267-E271. PubMed ID: 29149122
[TBL] [Abstract][Full Text] [Related]
2. Hyperleukocytosis in infant acute leukemia: a role for manual exchange transfusion for leukoreduction.
Runco DV; Josephson CD; Raikar SS; Goldsmith KC; Lew G; Pauly M; Fasano RM
Transfusion; 2018 May; 58(5):1149-1156. PubMed ID: 29399859
[TBL] [Abstract][Full Text] [Related]
3. Redefining hyperviscosity in acute leukemia: Potential implications for red cell transfusions in the microvasculature.
Musick JO; Williams EK; Fibben KS; Zhang DY; Caruso C; Sakurai Y; Tran R; Kemp ML; Lam WA
Am J Hematol; 2024 Jun; 99(6):1103-1107. PubMed ID: 38572662
[TBL] [Abstract][Full Text] [Related]
4. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
Bewersdorf JP; Zeidan AM
Cells; 2020 Oct; 9(10):. PubMed ID: 33080779
[TBL] [Abstract][Full Text] [Related]
5. Leukocytapheresis for the treatment of hyperleukocytosis secondary to acute leukemia.
Aqui N; O'Doherty U
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):457-60. PubMed ID: 25696894
[TBL] [Abstract][Full Text] [Related]
6. Rapid Fire: Acute Blast Crisis/Hyperviscosity Syndrome.
Emerson G; Kaide CG
Emerg Med Clin North Am; 2018 Aug; 36(3):603-608. PubMed ID: 30037446
[TBL] [Abstract][Full Text] [Related]
7. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
[No Abstract] [Full Text] [Related]
8. Hyperleukocytosis and leukostasis in acute and chronic leukemias.
Macaron W; Sargsyan Z; Short NJ
Leuk Lymphoma; 2022 Aug; 63(8):1780-1791. PubMed ID: 35357988
[TBL] [Abstract][Full Text] [Related]
9. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
Korkmaz S
Transfus Apher Sci; 2018 Feb; 57(1):4-7. PubMed ID: 29477941
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
